62 unchanged sentences
Moore has served as our Vice President and General Counsel since April 2020 and as Corporate Secretary since May 2020.
+Added: In February 2024, Mr.
+Added: Moore was promoted to Senior Vice President and Chief Legal Officer.
From October 2014 to April 2020, Mr.
11 unchanged sentences
Bloom has served on our Board of Directors since March 2022.
−Removed: In September 2023, after a 29-year career with Geron Corporation, a publicly traded clinical stage biopharmaceutical company, Ms.
+Added: In September 2023, after a 29-year career with Geron Corporation, a publicly traded commercial-stage biopharmaceutical company, Ms.
Bloom retired as Executive Vice President, Chief Financial Officer and Treasurer.
During that tenure, Ms.
−Removed: Bloom held several financial management positions, Chief Accounting Officer and Controller, as well as lead several operational functions, including purchasing, information technology and investor relations.
+Added: Bloom held several financial management positions, including Chief Accounting Officer and Controller, as well as lead several operational functions, including purchasing, information technology and investor relations.
Bloom started her career in public accounting at KPMG International Limited and became a Certified Public Accountant in 1994.
5 unchanged sentences
Beginning in 2006, Mr.
−Removed: Bowman served on the board of directors of Solexa, Inc., a DNA sequencing company, until its sale to Illumina, Inc., a publicly traded biotechnology
−Removed: company and leader in DNA sequencing in January 2007, after which Mr.
+Added: Bowman served on the board of directors of Solexa, Inc., a DNA sequencing company, until its sale to Illumina, Inc., a publicly traded biotechnology company and leader in DNA sequencing in January 2007, after which Mr.
Bowman continued to serve on the board of directors of Illumina, Inc.
69 unchanged sentences
Notes to Consolidated Financial Statements
−Removed: Reports of Independent Registered Public Accounting Firms
+Added: Report of Independent Registered Public Accounting Firm
Incorporated by Reference
3 unchanged sentences
Form of Common Stock Certificate of the Registrant.
−Removed: Warrant to Purchase Shares of Common Stock of Personalis, Inc., dated November 28, 2023, and expiring December 31, 2024 (the “First Warrant”).
−Removed: Warrant to Purchase Shares of Common Stock of Personalis, Inc., dated November 28, 2023, and expiring December 31, 2025 (the “Second Warrant”).
+Added: Investment Agreement, dated August 16, 2024, by and between the Registrant and Tempus AI, Inc.
+Added: Investment Agreement, dated December 19, 2024, by and between the Registrant and Merck Sharp & Dohme LLC.
Personalis, Inc.
9 unchanged sentences
Form of Indemnification Agreement entered into by and between the Registrant and each director and executive officer.
−Removed: Amended and Restated Non-Employee Director Compensation Policy, dated March 2, 2023.
+Added: Amended and Restated Non-Employee Director Compensation Policy, dated February 27, 2024
Amended and Restated Employment Agreement dated March 7, 2023, between the Company and Aaron Tachibana.
5 unchanged sentences
Second Amended and Restated Executive Severance Agreement, dated September 18, 2023, between the Company and Stephen Moore.
−Removed: Commercialization and Reference Laboratory Agreement, between Personalis, Inc.
−Removed: and Tempus AI, Inc.
−Removed: (f/k/a Tempus Labs, Inc.), dated November 25, 2023.
+Added: Commercialization and Reference Laboratory Agreement, between the Registrant and Tempus AI, Inc., dated November 25, 2023.
+Added: Amendment No.
+Added: 1 to the Commercialization and Reference Laboratory Agreement, dated August 16, 2024, by and between the Registrant and Tempus AI, Inc.
+Added: Amendment No.
+Added: 2 to the Commercialization and Reference Laboratory Agreement, dated September 20, 2024, by and between the Registrant and Tempus AI, Inc .
+Added: Amendment No.
+Added: 3 to the Commercialization and Reference Laboratory Agreement, dated December 13, 2024, by and between the Registrant and Tempus AI, Inc.
Lease, by and between MENLO PREHC I, LLC, MENLO PREPI I, LLC, TPI INVESTORS 9, LLC and the Registrant, dated February 2, 2015.
9 unchanged sentences
Department of Veterans Affairs and the Registrant, dated September 30, 2022.
+Added: Insider Trading Policy.
Subsidiaries of the Registrant as of December 31, 2024.
Consent of Independent Registered Public Accounting Firm.
−Removed: Consent of Independent Registered Public Accounting Firm.
Power of Attorney (included on the Signatures page of this Annual Report on Form 10-K).
36 unchanged sentences
(Principal Financial and Accounting Officer)
−Removed: Blaine Bowman
−Removed: February 28, 2024
−Removed: Blaine Bowman
/s/ Karin Eastham
1 unchanged sentence
Karin Eastham
−Removed: /s/ Kenneth Widder
−Removed: February 28, 2024
−Removed: /s/ Lonnie Shoff
−Removed: February 28, 2024
/s/ Olivia Bloom
February 27, 2025
+Added: Blaine Bowman
+Added: February 27, 2025
+Added: Blaine Bowman
/s/ Woodrow A.
1 unchanged sentence
Myers, Jr., M.D.
+Added: /s/ Lonnie Shoff
+Added: February 27, 2025
+Added: /s/ Kenneth Widder
+Added: February 27, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.